Mar 13, 2008 7:30am EDT Rigel Announces Participation in Upcoming Investor and Partnering Conferences
Jan 09, 2008 7:30am EST Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
Dec 13, 2007 7:30am EST Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
Dec 06, 2007 7:30am EST Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
